FAKTOR-OPTIONSSCHEIN - BRISTOL-MYERS SQUIBB

FAKTOR-OPTIONSSCHEIN - BRISTOL-MYERS SQUIBB Share Price

DE000SU1H3S2

Delayed Deutsche Boerse AG 09:04:47 05/06/2024 pm IST
0.16 ^EUR	-11.11%

Current month	+12.50%
1 month	-48.57%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart BRISTOL-MYERS SQUIBB COMPANY

Chart FAKTOR-OPTIONSSCHEIN - BRISTOL-MYERS SQUIBB

Latest news about BRISTOL-MYERS SQUIBB COMPANY

I-Mab Collaborates With Bristol-Myers to Evaluate Givastomig in Combination Study for Gastric, Esophageal Cancers	07:23pm	MT
Bristol Myers Squibb Announces Opdivo Plus Yervoy Significantly Improved Overall Survival Compared to Lenvatinib or Sorafenib as First-Line Treatment for Patients with Advanced Hepatocellular Carcinoma	04:59pm	AQ
I-Mab Announces Collaboration with Bristol Myers Squibb to Evaluate Givastomig in a Combination Study for Newly Diagnosed Gastric and Esophageal Cancers	04:30pm	CI
Bristol-Myers Squibb Says Opdivo Plus Yervoy Therapy Improves Survival of Liver Cancer Patients	04/06	MT

More news

Quotes 5-day view

Date	Price	Change
05/24/05	0.16	-11.11%
04/24/04	0.18	-5.26%
03/24/03	0.19	+18.75%
31/24/31	0.16	+14.29%
30/24/30	0.14	0.00%

Delayed Quote Deutsche Boerse AG

Last update June 05, 2024 at 09:04 pm IST

More quotes

Static data

Product type	Exotic Products
Buy / Sell	CALL
Underlying	BRISTOL-MYERS SQUIBB COMPANY
Issuer	Société Générale
WKN	SU1H3S
ISIN	DE000SU1H3S2
Date issued	02/11/2023
Strike	51.48 $
Maturity	Unlimited
Parity	1 : 1
Emission price	10.43 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	12.74 €
Lowest since issue	0.13 €
Spread	0.01 €
Spread %	5.88%

Company Profile

Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques. The United States account for 70.1% of net sales.

Sector

More about the company

Ratings for Bristol-Myers Squibb Company

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Consensus: Bristol-Myers Squibb Company

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

41.75 USD

Average target price

53.19 USD

Spread / Average Target

+27.41%

Consensus